Colibactin‐positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer
Year: 2020
Type: article
Abstract: Colibactin‐producing E. coli (CoPEC) are frequently detected in colorectal cancer (CRC) and exhibit procarcinogenic properties. Because increasing evidence show the role of immune environment and especially of antitumor T‐cells in CRC development, we investigated the impact of CoPEC on these cells in human CRC and in the APC Min/+ mice colon. T‐cell density was evaluated by immunohistochemistry in human tumors known for their CoPEC status. APC min/+ mice were chronically infected with a CoPEC strain (11G5). Immune cells (neutrophils and T‐cell populations) were then quantified by immunofluorescent staining of the colon. The quantification of lymphoid populations was also performed in the mesenteric lymph nodes (MLNs). Here, we show that the colonization of CRC patients by CoPEC is associated with a decrease of tumor‐infiltrating T lymphocytes (CD3 + T‐cells). Similarly, we demonstrated, in mice, that CoPEC chronic infection decreases CD3 + and CD8 + T‐cells and increases colonic inflammation. In addition, we noticed a significant decrease in antitumor T‐cells in the MLNs of CoPEC‐infected mice compared to that of controls. Moreover, we show that CoPEC infection decreases the antimouse PD‐1 immunotherapy efficacy in MC38 tumor model. Our findings suggest that CoPEC could promote a procarcinogenic immune environment through impairment of antitumor T‐cell response, leading to tumoral resistance to immunotherapy. CoPEC could thus be a new biomarker predicting the anti‐PD‐1 response in CRC.
Source: International Journal of Cancer
DOI: 10.1002/ijc.32920
Authors: Amélie Lopès, Elisabeth Billard, Al Hassan Casse, Romain Villéger, Julie Veziant, Gwenaëlle Roche, Guillaume Carrier, Pierre Sauvanet, Arnaud Briat, Franck Pagès, Souad Naimi, Denis Pezet, Nicolas Barnich, Bruno Dumas, Mathilde Bonnet
Institutions: Inserm, Université Clermont Auvergne, Sanofi (France), Microbe, Intestine, Inflammation and Host Susceptibility, Imagerie Moléculaire et Stratégies Théranostiques, Sorbonne Université, Centre de Recherche des Cordeliers, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Laboratoire d’immunologie intégrative du cancer, Université Paris Descartes, Université Pierre-et-Marie-Curie
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Sanofi, Danish Cancer Society Research Center, Agence Nationale de la Recherche, Institut National de la Santé et de la Recherche Médicale, Association Nationale de la Recherche et de la Technologie, Ligue Contre le Cancer, Conseil Régional d'Auvergne, Institut National de la Recherche Agronomique, Université Clermont-Auvergne
OpenAlex ID: W3006318834
